Evidence map›Paper›PMID 27580246›Full record

ArticleAnnals of the American Thoracic Society2016

IFN-γ Release Assay Result Is Associated with Disease Site and Death in Active Tuberculosis.

Sara C Auld, Scott H Lee, Eleanor S Click, Roque Miramontes, Cheryl L Day, Neel R Gandhi, Charles M Heilig

Open access · greenAbstract read
In one paragraph

Article in Annals of the American Thoracic Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sara C Auld1 Division of Pulmonary and Critical Care Medicine, Emory University School of Medicine, Atlanta, Georgia.
Scott H Lee2 Center for Surveillance, Epidemiology, and Laboratory Services.
Eleanor S Click3 Division of Global HIV/Tuberculosis, and.
Roque Miramontes4 Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia.
Cheryl L Day5 Emory Vaccine Center and Department of Microbiology, Emory University, Atlanta, Georgia; and.
Neel R Gandhi6 Departments of Epidemiology, Global Health, and Medicine, Emory University Rollins School of Public Health and School of Medicine, Atlanta, Georgia.
Charles M Heilig2 Center for Surveillance, Epidemiology, and Laboratory Services.
Emory University · USCenter for Surveillance, Epidemiology, and Laboratory Services · USCenters for Disease Control and Prevention · US

Funding

Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TBR01AI087465 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2010 to 2014
$3.9M
Transmission of HIV-Associated XDR TB in Rural South AfricaR01AI089349 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2010 to 2014
$3.7M
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global HealthK24AI114444 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2014 to 2023
$1.8M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalTL1TR000456 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$1.2M
NCATS NIH HHS TL1 TR000456NCATS NIH HHS UL1 TR000454NIAID NIH HHS K24 AI114444NIAID NIH HHS R01 AI087465NIAID NIH HHS R01 AI089349
6 · The paper itself

Abstract

rationaleThe IFN-γ release assays and tuberculin skin tests are used to support the diagnosis of both latent and active tuberculosis. However, we previously demonstrated that a negative tuberculin test in active tuberculosis is associated with disseminated disease and death. It is unknown whether the same associations exist for IFN-γ release assays.

objectivesTo determine the association between these tests and site of tuberculosis and death among persons with active tuberculosis.

methodsWe analyzed IFN-γ release assays and tuberculin test results for all persons with culture-confirmed tuberculosis reported to the U.S. National Tuberculosis Surveillance System from 2010 to 2014. We used logistic regression to calculate the association between these tests and site of disease and death. MEASUREMENTS AND MAIN

resultsA total of 24,803 persons with culture-confirmed tuberculosis had either of these test results available for analysis. Persons with a positive tuberculin test had lower odds of disseminated disease (i.e., miliary or combined pulmonary and extrapulmonary disease), but there was no difference in the odds of disseminated disease with a positive IFN-γ release assay. However, persons who were positive to either of these tests had lower odds of death. An indeterminate IFN-γ release assay result was associated with greater odds of both disseminated disease and death.

conclusionsDespite perceived equivalence in clinical practice, IFN-γ release assays and tuberculin test results have different associations with tuberculosis site, yet similar associations with the risk of death. Furthermore, an indeterminate IFN-γ release assay result in a person with active tuberculosis is not unimportant, and rather carries greater odds of disseminated disease and death. Prospective study may improve our understanding of the underlying mechanisms by which these tests are associated with disease localization and death.

Indexed as

Interferon-gamma Release TestsAdolescentAdultAgedChildChild, PreschoolFemaleHumansInfantInfant, NewbornKaplan-Meier EstimateLogistic ModelsMaleMiddle AgedMycobacterium tuberculosisPublic Health SurveillanceMycobacterium tuberculosispublic health surveillancetuberculin test

Identifiers

PMID27580246
PMCPMC5466186
OpenAlexW2518225469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.